Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Neil Ferguson and Azra Ghani.
Neil Ferguson
Connection Strength
2.286
Azra Ghani
  1. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021 08 02; 73(3):e754-e764.
    View in: PubMed
    Score: 0.240
  2. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis. Vaccine. 2021 05 21; 39(22):2995-3006.
    View in: PubMed
    Score: 0.235
  3. Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China. Int J Infect Dis. 2021 Jan; 102:463-471.
    View in: PubMed
    Score: 0.228
  4. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science. 2020 07 24; 369(6502):413-422.
    View in: PubMed
    Score: 0.222
  5. COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply. Lancet Infect Dis. 2021 01; 21(1):28.
    View in: PubMed
    Score: 0.221
  6. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 06; 20(6):669-677.
    View in: PubMed
    Score: 0.219
  7. Viral replication under combination antiretroviral therapy: a comparison of four different regimens. J Acquir Immune Defic Syndr. 2002 Jun 01; 30(2):167-76.
    View in: PubMed
    Score: 0.064
  8. The impact of a COVID-19 lockdown on work productivity under good and poor compliance. Eur J Public Health. 2021 10 26; 31(5):1009-1015.
    View in: PubMed
    Score: 0.061
  9. Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries. Int J Epidemiol. 2021 07 09; 50(3):753-767.
    View in: PubMed
    Score: 0.060
  10. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Sci Transl Med. 2021 07 14; 13(602).
    View in: PubMed
    Score: 0.060
  11. The J-IDEA Pandemic Planner: A Framework for Implementing Hospital Provision Interventions During the COVID-19 Pandemic. Med Care. 2021 05 01; 59(5):371-378.
    View in: PubMed
    Score: 0.059
  12. Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria. Nat Commun. 2021 04 22; 12(1):2394.
    View in: PubMed
    Score: 0.059
  13. State-level tracking of COVID-19 in the United States. Nat Commun. 2020 12 03; 11(1):6189.
    View in: PubMed
    Score: 0.057
  14. Host or pathogen-related factors in COVID-19 severity? - Authors' reply. Lancet. 2020 10 31; 396(10260):1397.
    View in: PubMed
    Score: 0.057
  15. Adapting hospital capacity to meet changing demands during the COVID-19 pandemic. BMC Med. 2020 10 16; 18(1):329.
    View in: PubMed
    Score: 0.057
  16. Response to COVID-19 in South Korea and implications for lifting stringent interventions. BMC Med. 2020 10 09; 18(1):321.
    View in: PubMed
    Score: 0.057
  17. Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment. Wellcome Open Res. 2020; 5:81.
    View in: PubMed
    Score: 0.057
  18. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020 09; 8(9):e1132-e1141.
    View in: PubMed
    Score: 0.056
  19. Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lancet. 2020 06 20; 395(10241):e110-e111.
    View in: PubMed
    Score: 0.055
  20. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 08; 584(7820):257-261.
    View in: PubMed
    Score: 0.055
  21. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect. 2006 Apr; 134(2):211-21.
    View in: PubMed
    Score: 0.021
  22. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis. 2004 Nov; 4(11):672-83.
    View in: PubMed
    Score: 0.019
  23. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004 Sep; 10(9):1653-6.
    View in: PubMed
    Score: 0.019
  24. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29; 359(1447):1091-105.
    View in: PubMed
    Score: 0.018
  25. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003 May 24; 361(9371):1761-6.
    View in: PubMed
    Score: 0.017
  26. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003 Jun 20; 300(5627):1961-6.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.